title: Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response.
abstract: The three-dimensional structure of the Fab fragment of an anti-2-phenyloxazolone monoclonal antibody (NQ10/12.5) in its native and complexed forms has been determined at 2.8 and 3.0 A resolution, respectively. Identification of hapten-contacting residues has allowed us to evaluate the contribution of individual somatic point mutations to maturation of the immune response. In particular, amino acid residues 34 and 36 of the light chain, which are frequently mutated in antibodies with increased affinity for 2-phenyloxazolone, are shown to interact directly with the hapten. We propose that the strict maintenance of certain amino acid sequences at the potentially highly variable VL-JL and VH-D-JH junctions observed among anti-2-phenyloxazolone antibodies is due largely to structural constraints related to antigen recognition. Finally, the three-dimensional model of NQ10/12.5, which uses the typical light chain of primary response anti-2-phenyloxazolone antibodies but a different heavy chain, allows an understanding of how, by preserving key contact residues, a given heavy chain may be replaced by another, apparently unrelated one, without loss of hapten binding activity and why the V kappa Ox1 germline gene is so frequently selected amongst the other known members of this family.
authors.affiliation: Département d'Immunologie, Institut Pasteur, Paris, France.
authors.forename: P M
authors.initials: PM
authors.lastname: Alzari
authors.forename: S
authors.initials: S
authors.lastname: Spinelli
authors.forename: R A
authors.initials: RA
authors.lastname: Mariuzza
authors.forename: G
authors.initials: G
authors.lastname: Boulot
authors.forename: R J
authors.initials: RJ
authors.lastname: Poljak
authors.forename: J M
authors.initials: JM
authors.lastname: Jarvis
authors.forename: C
authors.initials: C
authors.lastname: Milstein
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000235:genetics* / Q000276:immunology; D003460:Crystallization; D006241:Haptens; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D007143:Immunoglobulin Heavy Chains / Q000737:chemistry / Q000235:genetics* / Q000276:immunology; D007147:Immunoglobulin Light Chains / Q000737:chemistry / Q000235:genetics* / Q000276:immunology; D008024:Ligands; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation; D010081:Oxazolone / Q000031:analogs & derivatives* / Q000276:immunology; D011487:Protein Conformation; D014961:X-Ray Diffraction
chemical_list: D000911:Antibodies, Monoclonal; D006241:Haptens; D007140:Immunoglobulin Fab Fragments; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D008024:Ligands; C018361:2-phenyloxazolone; D010081:Oxazolone